GMO's portfolio update highlights key stock adjustments and forecasts a promising 9.6% return for International Deep Value ...

Cigna's strong growth potential, Evernorth expansion, and stock buybacks make it undervalued. Click here to find out why CI ...

Elevance Health says its acquisition of Verily’s Granular Insurance is designed to bolster its offerings to self-funded ...

The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.

Reports Q4 revenue $646.5M, consensus $650.9M. Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, “Evolent delivered ...

INDIANAPOLIS (AP) — INDIANAPOLIS (AP) — Elevance Health Inc. (ELV) on Thursday reported fourth-quarter net income of $418 million. The Indianapolis-based company said it had net income of $1. ...

For the current quarter ending in March, Evolent Health said it expects revenue in the range of $440 million to $470 million. The company expects full-year revenue in the range of $2.06 billion to ...

For the quarter ended December 2024, Evolent Health (EVH) reported revenue of $646.54 million, up 16.3% over the same period last year. EPS came in at -$0.02, compared to $0.23 in the year-ago quarter ...

Evolent Health (EVH) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.23 per share a year ago. These figures are adjusted ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...